Beta Finch - S&P 100 - EN

More earnings analysis: https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take the numbers and the noise from corporate earnings calls and turn them into something you can actually digest. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Zoetis, ticker ZTS, the animal health giant. Q2 2026 results, and Alex, this one's a bit of a bumpy ride.

ALEX: It really is. But before we get into it — quick disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good to have that out front. So let's set the scene. Zoetis reported second quarter revenue of $2.5 billion — flat on a reported basis, actually down 1% organically. Adjusted net income came in at $781 million, down 2% organically. And here's the headline: they cut full-year guidance.

ALEX: Yeah, this wasn't a small tweak either. New revenue guidance is $9.12 to $9.32 billion, which works out to a decline of 3% to 1% for the year. Adjusted net income guidance dropped to a range implying a decline of 9% to 5%. That's a meaningful reset.

JORDAN: So what happened? Basically, the U.S. Companion Animal business — think dogs and cats, not cattle and chickens — got hit hard. Revenue there was down 11% in the U.S. Fewer vet visits, pet owners being more price-conscious, and a lot more competitors piling into categories Zoetis basically invented, like dermatology treatments.

ALEX: Right, and that's the key tension here. Their blockbuster drug Apoquel and the whole Key Dermatology franchise — U.S. dermatology revenue was down 18% in the quarter. New competitors are using aggressive discounting and rebates to steal share, and it's not growing the overall market, it's just splitting up a shrinking pie.

JORDAN: Even so, Zoetis still holds about 86% in-clinic share in U.S. dermatology, even after losing 10 points year-over-year. So they're still dominant, just under real pressure for the first time in a while.

ALEX: And parasiticides — flea, tick, heartworm meds like Simparica — were basically flat globally, with the U.S. side down 6%. Management said it's less about a specific competitor and more about a broader pullback in vet visits.

JORDAN: But here's the plot twist — it's not all bad news. Livestock had a phenomenal quarter, up 11% globally, and 23% in the U.S., partly boosted by demand for cattle parasiticides tied to that New World screwworm outbreak. And Diagnostics grew 12%, driven by point-of-care testing demand.

ALEX: So basically, the pet side is struggling, but the farm animal side and the diagnostics side are picking up a lot of the slack.

JORDAN: Exactly — that diversification is doing real work for them right now.

ALEX: Let's talk strategy, because CEO Kristin Peck was pretty clear about their playbook. Instead of cutting list prices — which she called a "permanent structural change" — they're doing what's called gross-to-net investment. Basically targeted rebates, promotions, and bundling deals to protect market share without blowing up their pricing structure long-term.

JORDAN: It's a defend-the-fort strategy. Protect volume and share now, keep the sticker price intact, and hope the competitive intensity eases once the market sorts itself out. CFO Wetteny Joseph said full-year price realization could land anywhere from flat to down 2%, depending on how aggressive they need to get.

ALEX: There's also a leadership shakeup worth mentioning. Wetteny Joseph, the CFO, is stepping down after five years — a new hire, Jay Saccaro, is coming in not just as CFO but in a newly created combined CFO and Chief Operating Officer role, overseeing manufacturing and supply chain too. That's a pretty significant restructuring of the C-suite, aimed at s

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
# Beta Finch Podcast Script: Zoetis Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results to help you understand what's really happening in the market. I'm Alex.

**JORDAN:** And I'm Jordan. Before we dig in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Today we're breaking down Zoetis' Q1 2026 earnings - and wow, this was a quarter that really caught investors off guard. Jordan, what's your first take on these numbers?

**JORDAN:** Alex, this was definitely a reality check for the animal health giant. On the surface, flat organic operational revenue growth doesn't look terrible, but when you peel back the layers, there's a lot more going on here. They had about $100 million in sales that shifted from Q4 2025 into Q1 due to fiscal year alignment changes. Without that boost, they would have seen a 5% organic operational decline.

**ALEX:** That's a significant difference. And CEO Kristin Peck was pretty candid about what went wrong, wasn't she?

**JORDAN:** Absolutely. She laid out four key factors that created what she called "a convergence of interconnected dynamics." First, rising prices at veterinary clinics led to lower clinic traffic - pet owners are feeling the pinch. Second, those same pet owners are showing increased price sensitivity, especially for premium products where Zoetis leads. Third, competition intensified across key categories like dermatology and parasiticides, with competitors using aggressive pricing. And fourth - this is crucial - these competitive launches didn't expand the overall market like they have historically.

**ALEX:** That last point seems really important. Historically, when new competitors entered Zoetis markets, the pie got bigger for everyone. But not this time?

**JORDAN:** Exactly. In the past, competition actually helped grow markets - think about how the parasiticide market expanded when new players came in. But this time, with pet owners being more price-conscious and visiting clinics less frequently, new entrants are just taking share from existing players rather than bringing new customers into the market.

**ALEX:** Let's talk specific numbers. How did their key franchises perform?

**JORDAN:** The companion animal business really struggled, particularly in the U.S. where it declined 11%. Their key dermatology franchise - which includes blockbusters like Apoquel and Cytopoint - fell 11% globally to $347 million. The Simparica parasiticide franchise was down 1% to $385 million globally, but that masks an 8% decline in the U.S. And their OA Pain products, Librela and Solensia, dropped 8% combined to $140 million.

**ALEX:** But it wasn't all bad news, right? I noticed livestock performed well.

**JORDAN:** That's the silver lining here. Livestock delivered 12% organic operational growth to $720 million, with broad-based strength across cattle, poultry, and swine. Favorable producer economics and strong protein demand are driving investment in herd health. It really shows the value of Zoetis' diversified portfolio - when companion animal struggles, livestock can pick up some slack.

**ALEX:** What about guidance? I imagine they had to adjust expectations.

**JORDAN:** They definitely had to recalibrate. Full-year revenue growth guidance came down to 2-5% from what was presumably higher expectations, and adjusted net income growth is now expected at 2-6%. CFO Wetteny Joseph noted that while the fiscal year alignment was supposed to provide a 200-250 basis point tailwind, the challenging operating environment more than offset that benefit.

**ALEX:** During the Q&A, there were some pointe

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
**BETA FINCH PODCAST SCRIPT**

---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan to dive into Zoetis' Q4 2025 earnings call. Jordan, this was quite the earnings report from the animal health giant.

JORDAN: Absolutely, Alex. But before we jump into the numbers, I need to share an important disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that, Jordan. Now, let's talk Zoetis. The company reported some solid numbers for 2025 - $9.5 billion in revenue with 6% organic operational growth, and adjusted net income growing 7% organically. They hit the high end of their November guidance range.

JORDAN: That's right, and what I found particularly interesting is how their international markets really carried the load here. International delivered 8% organic operational revenue growth while the U.S. was at 4%. It really shows the value of having that global diversification, especially when you're dealing with some headwinds in your home market.

ALEX: Speaking of headwinds, CEO Kristin Peck was pretty candid about what they're seeing in the U.S. veterinary market. She mentioned economic pressure on Gen Z and millennial pet owners, which has led to declining therapeutic visits. But here's the fascinating part - emergency and urgent care are still showing strength.

JORDAN: That's such an important distinction, Alex. It's not that pet owners love their animals any less or that underlying demand for care is declining. It's more about price sensitivity and tighter household budgets when it comes to routine care. Pet owners are still bringing their dogs in when they're sick, but they're being more selective about wellness visits.

ALEX: Exactly. And Peck mentioned that clinics are starting to react by taking a more measured approach to the overall cost of care. The company is responding with targeted actions - optimizing their channel mix, increasing outreach to veterinarians, and reinforcing their scientific leadership through expanded medical education.

JORDAN: Let's talk about their star performer - the Simparica franchise. This is really impressive stuff. The franchise grew 12% operationally for the year, with Simparica Trio hitting over $1 billion in U.S. sales alone. That makes it their first brand to cross that billion-dollar threshold in the U.S.

ALEX: And globally, Trio maintained its position as the number one selling canine brand. What I found interesting is their omnichannel strategy - they're seeing double-digit contributions from retail and home delivery channels, which is helping them navigate those headwinds in traditional veterinary clinics.

JORDAN: That's smart positioning. They're essentially meeting customers where they want to shop, whether that's at the vet, at retail, or having products delivered to their home. It's all about convenience and compliance for pet owners.

ALEX: Now, let's address the elephant in the room - their OA pain franchise. This declined 3% operationally, with Librela specifically down 6%. This has been a challenge for Zoetis, and there have been some safety concerns raised about these monoclonal antibody treatments.

JORDAN: Right, but Peck seemed confident about their multipronged strategy to turn this around. She mentioned they're seeing stabilizing monthly sales trends and that veterinarian and pet owner satisfaction remains high. Plus, they're introducing new products like Lanivia and Portela to expand their OA pain portfolio.

ALEX: The guidance for 2026 is what really caught my attention, Jordan. They're projecting 3% to 5% organic operatio

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: ENERGY (https://betafinch.com/groups/ENERGY)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown for the companies moving the market. I'm Alex, joined as always by Jordan. Today we're diving into ExxonMobil's second quarter 2026 results — and this one's a doozy, because the backdrop was serious geopolitical disruption.

Before we get into it — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Yeah, so let's set the scene. This quarter played out against the Middle East conflict, which knocked out roughly 10% of Exxon's upstream production. That's a huge hit operationally.

ALEX: Right, but here's the headline — despite losing a tenth of their production, Exxon still posted $14.5 billion in earnings and $23.6 billion in cash flow from operations. That's industry-leading, disruption or not.

JORDAN: It really speaks to the diversification strategy. Outside the Middle East, upstream production actually hit its highest level in over two decades. And chemical margins jumped about 180% quarter-over-quarter because their North American plants stepped in to cover the supply shortfall.

ALEX: Let's talk Guyana, because this was the star of the Q&A. Production hit about 900,000 barrels a day gross, a fifth FPSO — that's a floating production vessel — set sail in June, and there's already talk of a ninth one being evaluated.

JORDAN: The really interesting nugget is what CFO Neil Hansen called an "inflection point." Exxon has now recovered its full $55 billion investment in Guyana almost two years ahead of schedule. Under the contract structure, once you hit that recovery cap, more of the revenue flows straight to free cash flow instead of being funneled back into cost recovery.

ALEX: So less volume growth going forward, but way more cash hitting the bottom line.

JORDAN: Exactly — management was clear multiple times: "this is about value, not volume." They're projecting free cash flow from Guyana to roughly double by 2030 compared to 2025.

ALEX: Now, refining — this is where it got really interesting given the Strait of Hormuz situation. CEO Darren Woods pointed out there's about 3 million barrels a day of refining capacity offline globally right now between the Strait closure, China halting exports, and Ukraine's strikes on Russian refineries.

JORDAN: And Exxon's positioned well for that because of a decade of portfolio high-grading — they shed weaker refineries and invested in the strong ones. Their Gulf Coast operations ran at over 95% reliability this quarter and delivered record second-quarter diesel production.

ALEX: One analyst pushed back a bit, though, noting refining earnings looked softer than some peers expected. Management chalked that up to volatility making margins hard to model in the moment, not any underlying operational issue.

JORDAN: Specialty products was actually a quiet standout — record quarterly and first-half earnings, best-ever basestock margins. Their integrated value chain let them pivot around the crude supply disruptions better than competitors.

ALEX: There was also a notable corporate move — Exxon officially redomiciled from New Jersey to Texas on July 1st, aligning their legal home with where they've actually operated for decades. Shareholders overwhelmingly approved it.

JORDAN: And don't sleep on the cost story. Structural cost savings are now at $16.3 billion cumulative since 2019, on track for $20 billion by 2030. They're basically holding cash costs flat year-over-year despite inflation and continued growth spending — that's the discipline that's funded all this shareholder return.

ALEX: Speaking of which — over $9 billion returned to shareholders this quarter through dividends and buybacks, plus more than

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: ENERGY (https://betafinch.com/groups/ENERGY)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Exxon Mobil's Q1 2026 earnings call - and wow, what a quarter to unpack. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And right off the bat, we need to address the elephant in the room - this earnings call was dominated by the ongoing Middle East conflict and its impact on global energy markets. CEO Darren Woods opened with some pretty sobering commentary about the situation.

**ALEX**: Absolutely. Woods was very direct about the human cost first, mentioning their colleagues and partners living under daily threats in the region. But from a business perspective, Jordan, the disruption has actually highlighted Exxon's competitive advantages in a major way.

**JORDAN**: Exactly. What struck me was how Woods framed this as essentially a stress test for all the changes they've made over the past decade. And by most measures, they seem to have passed with flying colors. Despite what he called "unprecedented disruption in the world supply of oil and natural gas," they maintained deliveries globally and even ramped up refining production by 200,000 barrels per day from February to March.

**ALEX**: That's like adding a mid-sized refinery overnight! And the financial results reflect this operational excellence. Even excluding timing effects and identified items, their first-quarter earnings per share were up versus 2025. CFO Kathy Mikells highlighted that their Energy Products segment made $2.8 billion in the quarter - that's up $2 billion from last year.

**JORDAN**: The refining story is particularly compelling. Remember when Exxon announced that Beaumont refinery expansion back in 2023? There were lots of questions about whether refining investments made sense. Well, Woods announced that expansion has already fully recovered its initial investment - ahead of expectations.

**ALEX**: And they're not just benefiting from higher margins - they're creating structural advantages. Their Gulf Coast refineries ran at record utilization rates, and they've got this global supply chain organization that rapidly executed alternate routings from the US Gulf Coast to Asia. It's that scale and integration advantage Woods keeps talking about.

**JORDAN**: Speaking of scale advantages, let's talk about their growth engines. In Guyana, they hit record production levels again and have three new projects under construction. The Oahu project expects first oil late this year. But what I found interesting was their $100 million commitment over ten years for STEM education in Guyana - that's the kind of long-term relationship building that creates sustainable competitive advantages.

**ALEX**: And in the Permian, they're still on track for 1.8 million oil-equivalent barrels this year, with that longer-term target of 2.5 million. What's interesting is Woods' confidence that they're not seeing any plateau in opportunities there, unlike some competitors who've predicted resource constraints.

**JORDAN**: The LNG story is fascinating too. Golden Pass achieved first LNG in March - that's about a 5% increase in US LNG exports. And by the time all three trains are online, they'll increase current US exports by roughly 15%. But here's what's really notable - with the Middle East disruptions, that "long" LNG market everyone was predicting has essentially disappeared overnight.

**ALEX**: Right, and they've got Papua New Guinea and Mozambique LNG projects expecting final investment decisions later this year. Woods was pretty confident about their position

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: ENERGY (https://betafinch.com/groups/ENERGY)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode corporate quarterly results for everyday investors. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Exxon Mobil's Q4 2025 earnings call - and wow, there's a lot to unpack here.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, Exxon's CEO Darren Woods came out swinging in this call, talking about transformation and competitive advantages. What caught your attention first?

ALEX: The numbers are pretty impressive, Jordan. They hit 4.7 million oil equivalent barrels per day in upstream production - that's their highest annual company production in over 40 years. But what really stands out is Woods saying their unit earnings are more than double what they were in 2019 on a constant price basis.

JORDAN: That's a massive improvement. And they're not just talking about past performance - they've got some bold targets for 2030. Tell me about this "advantaged assets" strategy.

ALEX: So they're targeting 65% of production to come from what they call "advantaged assets" by 2030. These are primarily their Permian Basin operations, Guyana offshore fields, and LNG projects. Woods emphasized these have "lower cost of supply, lower emissions intensity, and higher returns."

JORDAN: The Permian numbers are particularly striking. They hit 1.8 million barrels per day in Q4 - a new record. But here's what's interesting: they're deploying this "lightweight proppant" technology in about 25% of wells now, expecting to reach 50% by end of 2026. Woods said there's "no near-term peak Permian" for them and they expect to exceed 2.5 million barrels per day beyond 2030.

ALEX: That's the technology angle that keeps coming up. They've got over 40 what they call "stackable technologies" in various stages of testing. It's not just about drilling more holes - it's about getting more oil out of each hole more efficiently.

JORDAN: And Guyana continues to be their crown jewel. Their Yellowtail project came online ahead of schedule, pushing gross production to about 875,000 barrels per day in Q4. Woods mentioned their first four floating production units are producing 100,000 barrels per day above the investment basis.

ALEX: There was an interesting exchange about Guyana's future too. An analyst asked about the license expiring in 2027 and the disputed waters with Venezuela. Woods seemed optimistic about resolving the border dispute through the International Court of Justice, and hinted that recent developments in Venezuela might make the naval environment "more friendly."

JORDAN: Speaking of Venezuela, that was probably the most intriguing part of the Q&A. Woods acknowledged he told the White House that Venezuela was currently "uninvestable" but said the Trump administration is committed to addressing that. He even offered to send a technical team to assess opportunities there.

ALEX: The geopolitical opportunities don't stop there. Woods mentioned they're looking at Libya, Iraq, and other markets where improved fiscal terms and legal frameworks could unlock significant resources. He emphasized that Exxon's technological advantages and project execution capabilities make them attractive partners for these resource-rich countries.

JORDAN: Let's talk about their broader transformation strategy. This isn't just about oil and gas anymore. They're moving into carbon capture and storage in a big way, with about 9 million tons per year of CO2 sequestration capacity across various projects.

ALEX: And here's something that caught my ear - they're in "very serious substantive convers

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**BETA FINCH: Walmart Q2 FY2027 Earnings Breakdown**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're digging into Walmart's fiscal second quarter 2027 results.

ALEX: Before we jump in — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good ground rules. So, Alex, Walmart just posted a really strong quarter. Where do we start?

ALEX: Let's start with the headline numbers. Enterprise sales grew 5% in constant currency — that's the top end of their guidance. Adjusted operating income was up over 17%, and EPS grew more than 19%. Walmart U.S. comps came in at 2.6%, Sam's Club U.S. hit 4.4%, and International was up nearly 8%, led by China and India.

JORDAN: But here's the twist — a good chunk of that operating income growth wasn't "organic," so to speak. Walmart received about $2.9 billion in tariff refunds this quarter, and that added roughly 750 basis points to operating income growth. Strip that out, and underlying profit growth was still solid — at the top end of their 7-10% guidance — but the headline number is inflated by a one-time item.

ALEX: Right, and CFO John David Rainey was upfront about this. He basically said, "look at Q2 and Q3 together" to get the real picture, because they're plowing a lot of that refund money right back into price cuts rather than just letting it flow to the bottom line.

JORDAN: Which explains the rollback numbers — Walmart U.S. had over 11,000 rollbacks by the end of the quarter, up from 7,200 at the end of Q1. That's a huge jump, and CEO John Furner called it one of the highest counts he can remember.

ALEX: It's a pretty deliberate strategy — take a windfall from tariff refunds, funnel it into lower prices on things like ground beef and pantry staples, and try to lock in market share. Furner mentioned food share gains were some of the strongest they've seen in a while.

JORDAN: And that's the bet, right? Price investments now, in hopes it builds durable trust and share gains that outlast the promotional period. Management was pretty candid that there's a lag — you see unit growth first, and the real payoff comes over months, not days.

ALEX: Let's talk about the stuff that weighed on results, too. Health and wellness was a real drag this quarter — that's their pharmacy business. New regulation called "Maximum Fair Price" for certain drugs hit comp sales by about 125 basis points, worse than they'd expected. They also lost the GLP-1 drug tailwind that helped in prior years.

JORDAN: Which is interesting because if you back out health and wellness, their core categories — grocery, general merchandise — have been remarkably steady, in that 3-4% range for two and a half years. So the topline wobble is really a pharmacy story, not a "Walmart is losing its core mojo" story.

ALEX: Now, the part I find genuinely exciting is the platform story — eCommerce, advertising, membership, Marketplace. Global eCommerce grew 23%. Advertising was up 38% globally. Marketplace in the U.S. grew 52%. And membership fee income hit an all-time high, up 17%.

JORDAN: This is the piece investors should really pay attention to. Rainey made a striking comparison — Walmart's U.S. comp was only about 2.5%, but operating income grew 10% excluding tariff effects. That's four times the revenue growth rate, and he said they haven't seen that kind of profit leverage relative to comp sales in two decades.

ALEX: Because these newer businesses — advertising, Marketplace, membership — carry much higher margins, and they're growing faster than the core retail business. Roughly half of profit growth this quarter came from those areas.

JORDAN: The

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and with me as always is Jordan. Today we're unpacking Walmart's Q1 2027 earnings - and folks, this retailer continues to surprise on multiple fronts.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Walmart just delivered their ninth consecutive quarter of 20%+ eCommerce growth in the U.S. That's remarkable consistency for a company this size.

**JORDAN**: Absolutely, Alex. And the headline numbers are impressive across the board. Consolidated revenue grew nearly 6% in constant currency - that's 120 basis points above the top end of their guidance range. What really caught my attention though is how they're transforming their profit mix. Alternative revenue streams like advertising and membership now represent about one-third of operating income. That's a completely different Walmart than we saw even five years ago.

**ALEX**: Let's break down some of these key metrics. CEO John Furner mentioned they now have about 7,200 rollbacks in place - that's up 20% from last year. But the real story seems to be their speed game. They can now reach 60% of the U.S. population with delivery in 30 minutes or less. Jordan, what's driving this acceleration?

**JORDAN**: It's their omnichannel infrastructure finally hitting its stride, Alex. They delivered over 3.5 billion units same or next day globally this quarter. More than 36% of U.S. store-fulfilled deliveries arrived in under 3 hours - that's an 800 basis point improvement over just two years. And here's the kicker: their AI shopping agent "Sparky" is seeing weekly active users up over 100% quarter-over-quarter, with customers using Sparky spending 35% more on average.

**ALEX**: Speaking of technology, the automation story is fascinating. CFO John Rainey noted that about half of their eCommerce fulfillment center volume is now automated, and over 60% of stores receive freight from automated distribution centers. But they're dealing with some headwinds too - fuel costs hit them with about $175 million in unexpected expenses this quarter.

**JORDAN**: That fuel impact was significant - about 250 basis points of operating income growth. But here's what impressed me: they absorbed that hit and still reiterated their full-year guidance. Rainey was clear they're viewing this as a temporary cost to maintain their competitive position and drive market share gains. Transaction growth in the U.S. was their strongest in six quarters, so the strategy seems to be working.

**ALEX**: The marketplace business really stood out - 50% net sales growth in the U.S. They're expanding this globally too, launching cross-border marketplace capabilities into Canada and Mexico. How should investors think about this growth engine?

**JORDAN**: This is where the platform strategy gets exciting, Alex. They've built these capabilities once and now they're scaling globally. Marketplace growth of nearly 50% combined with their Walmart Fulfillment Services seeing 150% growth in same-day and next-day units - it's creating a flywheel effect. More sellers attract more selection, which drives more customers, which generates more advertising revenue. Their third-party marketplace advertising revenues alone grew over 50% year-over-year.

**ALEX**: Let's talk about the consumer environment because there were some interesting insights in the Q&A. They're seeing a real bifurcation - higher income customers spending with confidence while lower income consumers are more budget conscious. Rainey

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Walmart's Q4 2026 earnings, and wow - what a quarter this was.

JORDAN: Absolutely, Alex. Before we jump in though, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks Jordan. Now, let's talk numbers because Walmart absolutely crushed it. Revenue up 4.9% in constant currency, but here's the kicker - adjusted operating income grew 10.5%. That's more than double the sales growth rate.

JORDAN: That margin expansion is impressive, Alex. And it wasn't just one segment carrying the load. All three business segments - Walmart US, Sam's Club, and International - grew profits faster than sales. That's the kind of operational leverage investors love to see.

ALEX: The e-commerce story is particularly compelling here. Global e-commerce growth of 24%, with Walmart US hitting 27%. But Jordan, what really caught my attention was CEO John Furner talking about their AI shopping assistant "Sparky."

JORDAN: Oh, this is fascinating stuff. Customers who use Sparky have an average order value that's 35% higher than non-Sparky customers. And get this - roughly half of their app users have already tried Sparky. We're talking about AI-driven commerce moving from concept to reality at scale.

ALEX: It's like having a personal shopping assistant that understands your intent better than traditional search. Furner mentioned customers using fast delivery - that's under three hours - grew more than 60% for the year. They're not just selling stuff anymore; they're creating an ecosystem.

JORDAN: Exactly. And speaking of ecosystems, let's talk about their alternative profit streams. Advertising revenue hit $6.4 billion globally, up 37%. Walmart Connect in the US accelerated to 41% growth. Membership fees exceeded $4.3 billion. Alex, here's a stat that floored me - advertising income and membership fees combined represented nearly one-third of their operating income this quarter.

ALEX: That's a fundamental business model shift, Jordan. They're becoming less dependent on traditional retail margins and more like a platform company. CFO John David Rainey mentioned they've reached a point where they don't even talk about e-commerce profitability internally anymore - they're well past breakeven and seeing double-digit incremental margins.

JORDAN: The automation story is equally impressive. About 60% of US stores are receiving freight from automated distribution centers, and 50% of e-commerce fulfillment is automated. This isn't just about efficiency - it's about having real-time visibility into inventory and being able to promise customers exactly what they want, when they want it.

ALEX: Let's talk guidance because this is where Walmart shows confidence. They're projecting constant currency sales growth of 3.5% to 4.5% for fiscal 2027, but operating income growth of 6% to 8%. That's the margin expansion story continuing.

JORDAN: And they're putting their money where their mouth is with a $30 billion share repurchase program - their largest ever. With $42 billion in operating cash flow and 18% growth in free cash flow, they've got the financial firepower to invest while returning capital to shareholders.

ALEX: During the Q&A, there were some really telling moments. When asked about consumer health, Furner noted they're still seeing the majority of share gains from households making over $100,000, but even lower-income households are emphasizing convenience nearly as much as price. That's a huge shift.

JORDAN: The global expansion of their platforms i

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, here with Jordan, and today we're diving into Wells Fargo's second quarter 2026 results. Before we jump in — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And Alex, this was a genuinely strong quarter for Wells Fargo. Diluted EPS hit $2, up 25% year-over-year. Revenue grew 9%. Every single operating segment posted growth in both net interest income and non-interest income.

ALEX: That broad-based part is what jumps out to me. CEO Charlie Scharf made a point of saying it's not just a rising-rate-environment story — it's investments and operating discipline paying off. Headcount has now declined for 24 straight quarters, down to 197,000, while they're actually adding bankers, advisors, and traders in growth areas.

JORDAN: Right, they're funding growth with efficiency savings rather than just cutting costs across the board. And the returns numbers back it up — ROTCE jumped to 17.7% this quarter, up from 15.2% a year ago. CFO Mike Santomassimo did flag that venture capital gains — $847 million in equity gains — juiced that number a bit, but even stripping that out, the underlying trend is improving.

ALEX: Wells Fargo has a medium-term target of 17-18% ROTCE, and Scharf was asked repeatedly about timing on that. His answer, essentially: "we're more confident every quarter, but we're not giving you a hard date because rates and markets are unpredictable."

JORDAN: Classic executive hedge, but a reasonable one. Let's talk net interest income, because that's where most of the analyst questions went. Full-year guidance stayed at $50 billion, give or take, but the composition shifted a little — loan growth is coming in better than expected, while non-interest-bearing deposits aren't growing as much as they'd hoped.

ALEX: And net interest margin actually compressed again — down 4 basis points from Q1. Management's explanation is interesting: it's largely self-inflicted, in a good way. They're growing their markets business balance sheet aggressively, financing clients at lower spreads, which drags down NIM but drives higher trading revenue and deeper relationships.

JORDAN: Scharf was pretty emphatic about that point — he said NIM compression "is not happening to us," it's a deliberate choice they can reverse if the payoff isn't there. Markets revenue grew 24% year-over-year, so early signs suggest it's working. They expect a bit more NIM pressure in Q3, then stabilization in Q4.

ALEX: Loan and deposit growth were both double-digit — average loans up 12%, deposits up 10% — which is a big deal since Wells Fargo only got out from under the Fed's asset cap last year. They're finally playing offense after years of being constrained.

JORDAN: Credit quality remained a bright spot too. Net charge-offs declined 10 basis points year-over-year to 34 basis points. Consumer delinquencies are actually coming in better than their models predict. Commercial credit is clean as well, though Scharf did flag caution around wholesale lending — data center financing, leveraged deals — where non-bank lenders are taking on more risk than Wells is willing to.

ALEX: That data center commentary was one of my favorite exchanges. An analyst asked about second-derivative AI exposure, and Scharf gave a really thoughtful answer about how they underwrite different pieces of the data center supply chain differently — chip makers get paid back fast with huge margins, but other players in the chain carry much longer, riskier payback horizons.

JORDAN: It showed real discipline — they're not just chasing the AI infrastructure boom blindly. On the business-line side, the Cor

This episode includes AI-generated content.